❗Encouraging weight loss in #osteoarthritis is really challenging! @rheumarhyme But this slide👇 is reassuring and we can use it to motivate our patients. #ACR22 @rheumnow #acrreview https://t.co/hUa56UfJPA

Short-term intra-articular steroids are effective (unclear- long term benefits) - no increase risk for knee replacement with repeat steroid injx #osteoarthritis @rheumnow #acr22 #acrreview https://t.co/MJHXWePF70

Nice summary slide of the recently published 2022 Classification Criteria for GCA and TAK! Avalable free! TAK: https://t.co/0aMVPvKgyE GCA: https://t.co/s1aiFpq3r2 #ACR22 #Vasculitis22 @RheumNow https://t.co/x9ufxi7aco

• https://onlinelibrary.wiley.com/doi/full/10.1002/art.42324
• https://onlinelibrary.wiley.com/doi/full/10.1002/art.42325

Medicare will cover #DXA testing for these diagnoses ⁦@RheumNow⁩ #acr22 #acrreview https://t.co/keZg0fxyz9

Dr Scher shares his algorithm Rx for #PsA in clinical practice #acrreview #acr22 ⁦@RheumNow⁩ https://t.co/0xB1KwpfW7

Did You Know? FDA relaxed warnings on #sarcoma with #Forteo- can use more than 2 years ⁦@RheumNow⁩ #acr22 #acrreview #osteoporosis https://t.co/Xzr6TZIlWN

Drug holidays for #osteoporosis RX but be note fracture risk may increase with these holidays- consider an anabolic agent during these times - Dr Tanner #acr22 ⁦@RheumNow⁩ #acrreview https://t.co/6XbpYD5D1X

Dr Tanner presents the features of AFF👇 It is rare, subtrochanteric in location and often appears w/n 5-10 yrs of BP use. #ACR22 @RheumNow #acrreview #osteoporosis https://t.co/KbMJ4dXfpj

P1NP is a useful bone turnover marker that Dr. Tanner checks to monitor #osteoporosis therapy (if insurance covers it) - it is not affected by diurnal variation, food, renal function. #ACR22 @rheumnow #ACRReview

Here's a nice slide comparing Sjogren's disease and Sarcoidosis: #ACR22 @RheumNow #acrreview #MedTwitter https://t.co/MQQx3GBl5f

Abbvie launching another upadacitinib phase 3 trial w/essentially zero preliinary data I personally love this strategy; I think Phase 2's are an expensive waste of time Better to go big and answer the question? COI: I participate in SELECT-GCA #ACR22 @RheumNow #Vasculitis22 https://t.co/fSs3xt8baA

QD Clinic - When to Worry About Malignancy and Myositis Which myositis patients should you worry and screen for cancer? https://t.co/bfT0rYNS45 https://t.co/cf59fdxBuC

• https://bit.ly/3TnA9Rl

Tomorrow at 3 pm at #ACR22! Join my session on Difficult to treat RA - How do define it? - What are the patient and synovial characteristics? - How do we study it? @RheumNow https://t.co/43UEJhYvRp

Does #COVID19 #vaccine work in #psoriaticarthritis? @RheumNow #ACR22 Abstract #0389 🤚 HR for infection and hospitalization similar between controls and PsA after 2nd vaccination 🤚#Enbrel (OR 2.39) and #JAKi (OR 9.90) higher risk of infection and hospitalization

“Expert rheumatologist opinion remains the gold standard!” – Dr. J Scher on diagnosis of #axSpa I would like to think this quote applies to everything, not just to axSpa (-my own opinion) #ACRreview #ACR22 @rheumnow https://t.co/zpwQwXA8o2